Veena Singh, MD | Authors


Clinical Validation and Utility of a Liquid Biopsy in NSCLC

June 11, 2015

Veena Singh, MD, senior vice president and senior medical director, Biocept, Inc., discusses the clinical validation and utility of a liquid biopsy in non-small cell lung cancer (NSCLC) using circulating tumor cells (CTCs) and ctDNA to analyze EGFR, ALK and ROS status.